A Clinical Trial in Subjects With Atopic Dermatitis (Part 1)
Trial details
- Registry ID
- NCT05717920
- Phase
- Phase 2
Drug identity checked against registry records
Also recorded as ADX-629; Open-label
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Clinical Trial in Subjects With Atopic Dermatitis (Part 1)NCT05717920 | ALDX | Phase 2 | Completed | 2023-11-21Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |